Regulation of the c-jun gene in p210 BCR-ABL transformed cells corresponds with activity of JNK, the c-jun N-terminal kinase

Blood

Volumn 92, Issue 7, 1998, Pages 2450-2460

  Burgess, Gem S ^b   Williamson, Elizabeth A ^b   Cripe, Larry D ^b   Litz Jackson, Sara ^b   Bhatt, Jay A ^b   Stanley, Kurt ^b   Stewart, Mark J ^b   Kraft, Andrew S ^b   Nakshatri, Harikrishna ^b   Boswell, H Scott ^a  

^a INDIANA UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; PROTEIN KINASE;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; ENZYME ACTIVITY; ENZYME ASSAY; GENE ACTIVITY; GENE CONTROL; GENE EXPRESSION; IMMUNOBLOTTING; MOUSE; NONHUMAN; ONCOGENE C FOS; ONCOGENE C JUN; PRIORITY JOURNAL; PROTEIN ANALYSIS;

EID: 17444436617     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.7.2450     Document Type: Article

References (54)

1. Johnson R, Spiegelmen B, Hanahan D, Wisdom R: Cellular transformation and malignancy induced by ras requires c-jun. Mol Cell Biol 16:4504, 1996
2. Johnson RS, van Lingen B, Dapaioannoa VE, Spiegelman BM: A null mutation at the c-jun locus causes embryonic lethality and retarded cell growth in culture. Genes Dev 7:1309, 1993
3. Yang D, Tournier C, Wysk M, Lu HT, Xu J, Davis RJ: Targeted disruption of the MKK4 gene causes embryonic death, inhibition of c-jun NH2 terminal kinase activation, and detects in AP-1 transcriptional activity. Proc Natl Acad Sci USA 94:3004, 1997
4. Sanchez I, Hughes RT, Mayer BJ, Yee K, Woodgett JR, Avruch J, Kyriakis JM, Zon LI: Role of SAPK/ERK kinase 1 in the stress-activated pathway regulating transcription factor c-jun. Nature 372:794, 1994
5. Karin M: The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 270:16483, 1995
6. Gupta S, Cambell D, Derijard B, Davis RJ: Transcription factor ATF-2 regulation by the JNK signal transduction pathway. Science 267:389, 1995
7. Whitmarsh RJ, Yang H, Su MS, Sharrocks AD, Davis RJ: Role of p38 and JNK mitogen-activated protein kinases in the activation of ternary complex factors. Mol Cell Biol 17:2360, 1997
8. Angel P, Hattori K, Smeal T, Karin M: The jun protooncogene is positively autoregulated by its product, c-jun/AP-1. Cell 55:875, 1988
9. Smeal T, Binetruy R, Mercola D, Grover-Bardwick A, Heidecker G, Rapp UR, Karin M: Oncoprotein-mediated signaling cascade stimulates c-jun activity by phosphorylation of serines 63, 73. Mol Cell Biol 12:3207, 1992
10. Westwick JK, Cox AD, Der CJ, Cobb MH, Hibi M, Karin M, Brenner DA: Oncogenic ras activates c-jun via a separate pathway from the extracellular signal-regulated kinases. Proc Natl Acad Sci USA 91:6030, 1994
11. Minden A, Lin A, Claret FX, Abo A, Karin M: Selective activation of the JNK signaling cascade and c-jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell 81:1147, 1995
12. Coso OA, Chiarello M, Yu JC, Termoto H, Crespo P, Xu N, Miki T, Gutkind JS: The small GTP-binding proteins rac1 and cdc42 regulate the activity of the JNK/SAPK signaling pathway. Cell 81:1137, 1995
13. Adler V, Polotskaya A, Wagner F, Kraft AS: Affinity-purified c-jun amino terminal protein kinase requires serine/threonine phosphorylation for its activity. J Biol Chem 267:17001, 1992
14. Mandanas RA, Leibowitz DS, Gharehbaghi K, Tauchi T, Burgess GS, Miyazawa K, Jayaram HN, Boswell HS: Role of p21ras in p210 BCR-ABL transformation of murine myeloid cells. Blood 82:1838, 1993
15. Raitano AB, Halpern JR, Hambruch TM, Sawyers CL: The Bcr-Abl leukemia oncogene activates jun kinase and requires jun for transformation. Proc Natl Acad Sci USA 92:11746, 1995
16. Matsuguchi T, Salgia R, Hallek M, Eder M, Druker B, Ernst TJ, Griffin JD: She phosphorylation in myeloid cells is regulated by granulocyte-macrophage colony-stimulating factor, interleukin-3, and Steel factor and is constitutively increased by p210 BCR-ABL. J Biol Chem 269:5016, 1994
17. Stewart MJ, Litz-Jackson S, Burgess GS, Williamson EA, Leibowitz DS, Boswell HS: Role for E2F1 in p210 BCR-ABL downstream regulation of c-myc transcription initiation. Studies in murine myeloid cells. Leukemia 9:1499, 1995
18. Nakshatri H, Bhat-Nakshatri P: Differential effect of NP-40 on DNA binding of transcription factors. Anal Biochem 249:103, 1997
19. Nakshatri H, Bhat-Nakshatri P, Martin DA, Goulet RJ Jr, Sledge GW Jr: Constitutive activation of NF-kB during progression of breast cancer to hormone-independent growth. Mol Cell Biol 17:3629, 1997
20. Hibi M, Lin A, Smeal T, Minden A, Karin M: Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-jun activation domain. Genes Dev 7:2135, 1993
21. Mandanas RA, Boswell HS, Lu L, Leibowitz D: BCR-ABL confers growth factor independence upon a murine myeloid cell line. Leukemia 6:796, 1992
22. Conscience JF, Verrier B, Martin G: Interleukin-3 dependent expression of c-myc and c-fos protooncogenes in hematopoietic cell lines. EMBO J 5:317, 1986
23. Devary Y, Gottlieb RA, Lau LF, Karin M: Rapid and preferential activation of the c-jun gene during the mammalian UV response. Mol Cell Biol 11:2804, 1991
24. Herr I, van Damm H, Angel P: Binding of promoter-associated AP-1 is not altered during induction and subsequent repression of the c-jun promoter by TPA and UV irradiation. Carcinogenesis 15:1105, 1994
25. Pendergast AM, Quilliam LA, Cripe LD, Bassing CH, Dai Z, Li N, Batzer A, Rabun KM, Der CJ, Schlessinger J, Ghishisky M: BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the Grb-2 adaptor protein. Cell 75:175, 1993
26. Puil L, Liu J, Gish G, Mbamalu G, Bowtell D, Pelicci PG, Arlinghaus R, Pawson T: Bcr-Abl oncoproteins bind directly to activators of the Ras signaling pathway. EMBO J 13:764, 1994
27. Sawyers CL, McLaughlin J, Witte ON: Genetic requirement for ras in the transformation of fibroblasts and hematopoietic cells by the Bcr-Abl oncogene. J Exp Med 181:307, 1995
28. Nagata Y, Nishida E, Todokoro K: Activation of the JNK signaling pathway by erythropoietin, thrombopoietin, and interleukin-3. Blood 89:2664, 1997
29. Foltz IN, Schrader JW: Activation of the stress-activated protein kinases by multiple hematopoietic growth factors with the exception of interleukin-4. Blood 89:3092, 1997
30. VanAelst L, D'Souza-Schorey C: RhoGTPases and signaling networks. Genes Dev 11:2215, 1997
31. Sakai I, Kraft AS: The kinase domain of Jak2 mediates induction of bcl-2 and delays cell death in hematopoietic cells. J Biol Chem 272:12350, 1997
32. Matsuguchi T, Zhao Y, Lilly MB, Kraft AS: The cytoplasmic domain of granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor alpha subunit is essential for both GM-CSF-mediated growth and differentiation. J Biol Chem 272:17450, 1997
33. Sato N, Sakamaki K, Terado N, Arai K, Miyajima A: Signal transduction by the high-affinity GM-CSF receptor: Two distinct cytoplasmic regions of the common beta-subunit responsible for different signaling. EMBO J 12:4181, 1993
34. Crespo P, Schuebel KE, Ostrom AA, Gutkind JS, Bustelo XR: Phosphotyrosine-dependent activation of Rac1 GDP/GTP exchange by the vav protooncogene product. Nature 385:169, 1997
35. Crespo P, Bustelo XR, Aaronson DS, Coso OA, Lopez-Barahone M, Barbacid M, Gutkind JS: Rac1-dependent stimulation of the JNK/SAPK signaling pathway by vav. Oncogene 13:455, 1996
36. Fanger GR, Johnson NL, Johnson GL: MEK kinases are regulated by EGF and selectively interact with rac/Cdc42. EMBO J 16:4961, 1997
37. Matsuguchi T, Inhorn RC, Carlesso N, Xu G, Druker B, Griffin JD: Tyrosine phosphorylation of p95 vav in myeloid cells is regulated by GM-CSF, IL-3, and Steel factor, and is constitutively increased by p210 BCR-ABL. EMBO J 14:257, 1995
38. Russell M, Lange-Carter CA, Johnson GL: Direct interaction between ras and the kinase domain of mitogen-activated protein kinase kinase kinase (MEKK1). J Biol Chem 270:11757, 1995
39. Anafi M, Kiefer F, Gish GD, Mbamalu G, Iscove NN, Pawson T: SH2/SH3 adaptor proteins can link tyrosine kinases to a Ste20-related protein kinase, HPK1. J Biol Chem 272:27804, 1997
40. Lee W, Haslinger A, Karin M, Tjian R; Activation of transcription by two factors that bind promoter and enhancer sequences of the human metallothionein gene and SV40. Nature 325:368, 1987
41. Lazo JS, Kondo Y, Dellapiazza D, Michalskka AE, Choo KH, Pitt BR: Enhanced sensitivity to oxidative stress in cultured embryonic cells from transgenic mice deficient in metallothionein I and II genes. Cancer Res 51:5903, 1995
42. Kondo Y, Woo ES, Michalski AE, Choo KH, Lazo JS: Metallothionein null cells have increased sensitivity to anticancer drugs. Cancer Res 55:2021, 1995
43. Mulcahy RT, Gipp JJ: Identification of a putative antioxidant response element in the 5′ flanking region of the human gamma-glutamyl cysteine synthetase heavy subunit gene. Biochem Biophys Res Commun 209:227, 1991
44. Yao KS, Godwin AK, Johnson SW, Ozols RF, O'Dwyer PJ, Hamilton TC: Evidence for altered regulation of gamma-glutamyl cysteine synthetase gene expression among cisplatinum-sensitive and cis-platinum resistant human ovarian cancer cell lines. Cancer Res 55:4367, 1995
45. O'Brien ML, Tew KD: Glutathione and related enzymes in multidrug resistance. Eur J Cancer 32A:967, 1996
46. Friling RS, Bergelson S, Daniel V: Two adjacent AP-1 like binding sites from the electrophile-responsive element of murine glutathione-S-transferase Ya subunit gene. Proc Natl Acad Sci 89:668, 1992
47. Xia CL, Cowell IG, Dixon KH, Pemble SE, Ketterer B, Taylor JB: Glutathione transferase pi, its minimal promoter and downstream cis-acting element. Biochem Biophys Res Commun 209:227, 1991
48. Li Y, Jaiswal AK: Regulation of the human NAD(P)H: quinone reductase gene. Role of AP-1 binding site contained within human anti-oxidant response element. J Biol Chem 267:15097, 1992
49. Osborn MT, Chambers TC: Role of the stress-activated/c-jun NH2-terminal protein kinase pathway in the cellular response to adriamycin and other chemotherapeutic drugs. J Biol Chem 271:30950, 1996
50. Liu ZG, Baskaran R, Lea-Chou ET, Wood LD, Chen Y, Karin M, Wang JYJ: Three distinct signaling responses by murine fibroblasts to genotoxic stress. Nature 384:273, 1996
51. Irani K, Xia Y, Zweier JL, Sollott SJ, Der CJ, Fearon ER, Sandaresan M, Finkel T, Goldshmidt-Clermont PJ: Mitogenic signaling mediated by oxidants in ras-transformed fibroblasts. Science 275:1649, 1997
52. Amarante-Mendes GP, Kim CN, Liu L, Huang Y, Perkins CL, Green DR, Bhalla K: Bcr-Abl exerts its anti-apoptotic effect against diverse apoptotic stimuli through blockage of mitochondrial release of cytochrome C and activation of caspase 3. Blood 91:1700, 1998
53. Talley AK, Dewhurst S, Perry SW, Dollard SC, Gummuluru S, Fine SM, New D, Epstein LG, Gendelman HE, Gelbard HA: Tumor necrosis factor alpha-induced apoptosis in human neuronal cells: Protection by the antioxidant N-acetylcysteine and the genes bcl-x and crmA. Mol Cell Biol 15:2359, 1995
54. Zhang P, Liu B, Kang SW, Seo MS, Rhee SG, Obeid LM: Thioredoxin peroxidase is a novel inhibitor of apoptosis with a mechanims distinct from that of bcl-2. J Biol Chem 272:30615, 1997